Ammonul Medicis - Treatment for Urea Cycle Disorder
Ammonul is a combination of 10% sodium phenylacetate and 10% sodium
benzoate indicated as an adjunctive therapy for the treatment of
acute hyperammonemia and associated encephalopathy in patients with
deficiencies in enzymes of the urea cycle.
Posted: February 2005
Ammonul (sodium benzoate and sodium phenylacetate) FDA Approval History